ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0315

Sjögren’s Syndrome Symptom Diary (SSSD) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) as Assessments of Symptoms in Sjögren’s Syndrome: A Qualitative Exploration of Content Validity and Meaningful Change

Samantha Wratten1, Natasha Griffiths2, Carl Cooper2, Jessica Flynn2, Rebecca Hall3, Linda Abetz-Webb2, Wolfgang Hueber4, Briana Ndife5 and Pushpendra Goswami4, 1Adelphi Values, Macclesfield, United Kingdom, 2Adelphi Values, Bollington, United Kingdom, 3Adelphi Values Ltd, Bollington, United Kingdom, 4Novartis Pharma AG, Basel, Switzerland, 5Novartis, East Hanover, NJ

Meeting: ACR Convergence 2021

Keywords: autoimmune diseases, Fatigue, Measurement Instrument, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: The aim of this study was to gain qualitative patient feedback on the appropriateness of two Patient Reported Outcome (PRO) measures as assessments of symptoms of Sjögren’s. The Sjögren’s Syndrome Symptom Diary (SSSD) is a novel daily diary assessing the severity of six core symptoms: eye dryness, mouth dryness, skin dryness, genital dryness (females only), fatigue, and muscle/joint pain. Recently, the SSSD fatigue item wording has been updated to ‘tiredness’ and two supplementary items have been drafted to capture the most bothersome and most important to improve symptoms from a patient perspective. The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) is a well-established, 13-item measure of an individual’s fatigue and tiredness over the past week, however the content validity of the FACIT-F items has not been confirmed in Sjögren’s. In this study the 13-item FACIT-F and new and updated SSSD items were tested with patients with Sjögren’s. Patient perceptions of meaningful change on the SSSD were also explored.

Methods: Twelve semi-structured, cognitive telephone interviews were conducted with US adult patients with Sjögren’s to cognitively debrief the new SSSD items (‘most bothersome’ and ‘most important to improve’), and the updated SSSD ‘tiredness’ item. Cognitive debriefing involves actively testing a measure with patients to determine whether each instruction/item is understood as intended and relevant to patient experiences of the condition. In qualitative research a sample of 12 patients is typically considered sufficient to provide a comprehensive assessment of the PRO measure. Meaningful change was explored in relation to the six core SSSD items and for SSSD total average scores. Understanding and relevance of the 13 FACIT-F items were also explored.

Results: The new and updated SSSD items were well-understood by all patients (n=12/12) and all patients selected the same symptom as their most bothersome and the most important to improve from their perspective. The symptom most frequently reported as the most bothersome and important to improve was eye dryness (n=7/12). Meaningful improvement on individual SSSD items varied depending on patients’ current Sjögren’s severity, and meaningful improvement in relation to the SSSD total score varied from 1-point to 7-points (mean: 2.3 points; mode: 2 points). Such changes were described in relation to improvements in patients’ feeling and functioning. FACIT-F items were generally well-understood, although there were some instances of patients not understanding the term ‘listless’ (n=4/12) in the item ‘I feel listless (washed out)’. FACIT-F items were generally relevant; however, there was some variation in patient experiences of fatigue and tiredness related to Sjögren’s. The FACIT-F item ‘I am too tired to eat’ was not relevant to any patients.

Conclusion: These results suggest that the new and updated SSSD items, and FACIT-F items, have good content validity as PRO measures of Sjögren’s symptoms. Patient perceptions of meaningful change on the SSSD will be valuable for aiding interpretation of psychometrically-derived responder definitions and informing clinical trial endpoints.


Disclosures: S. Wratten, None; N. Griffiths, None; C. Cooper, None; J. Flynn, None; R. Hall, None; L. Abetz-Webb, None; W. Hueber, Novartis, 3, 11; B. Ndife, Novartis, 3, 11; P. Goswami, Novartis Pharma AG, 3.

To cite this abstract in AMA style:

Wratten S, Griffiths N, Cooper C, Flynn J, Hall R, Abetz-Webb L, Hueber W, Ndife B, Goswami P. Sjögren’s Syndrome Symptom Diary (SSSD) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) as Assessments of Symptoms in Sjögren’s Syndrome: A Qualitative Exploration of Content Validity and Meaningful Change [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/sjogrens-syndrome-symptom-diary-sssd-and-functional-assessment-of-chronic-illness-therapy-fatigue-facit-f-as-assessments-of-symptoms-in-sjogrens-syndrome-a-qualitative-explorati/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sjogrens-syndrome-symptom-diary-sssd-and-functional-assessment-of-chronic-illness-therapy-fatigue-facit-f-as-assessments-of-symptoms-in-sjogrens-syndrome-a-qualitative-explorati/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology